You have 9 free searches left this month | for more free features.

Condition

Gastric Cancer (1)

Lung Neoplasms (1)

Ovarian Cancer (1)

Prostate Cancer (1)

Small Cell Lung Cancer (1)

Small-cell Lung Cancer (1)

Urothelial Cancer (1)

Urothelial Carcinoma (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Ellipses Pharma (2)

National Cancer Institute (NCI) (1)

Collaborator

Intervention

ep0057 (3)

olaparib tablets (2)

olaparib (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

NIH (1)

Study Type

Interventional (3)

ep0057

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting

Urothelial Carcinoma
+4 more

EP0057
olaparib

Bethesda, Maryland

National Institutes of Health Clinical Center

Feb 2, 2023

Ovarian Cancer Trial in Hungary, United Kingdom, United States (EP0057, Olaparib tablets)

Recruiting

Ovarian Cancer

EP0057
Olaparib tablets

Lady Lake, Florida
+15 more

Mar 29, 2022

Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)

Not yet recruiting

Gastric Cancer
Small-cell Lung Cancer

EP0057
Olaparib tablets

Shanghai, Changning District, 交通大学邮政编码, China
+20 more

Nov 1, 2022